Literature DB >> 2921357

Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer.

T B Halvorsen1, E Seim.   

Abstract

Five hundred and twenty seven colorectal carcinomas were reviewed histologically. A multivariate analysis (Cox) was used to test the prognostic importance of certain histological features (invasiveness, inflammatory reaction, and amount of fibrous tissue) at the tumour edge after allowance had been made for clinicopathological stage, tumour site, and histological type and grade. A poorly defined tumour border, lack of inflammatory reaction, and a pronounced fibrosis (desmoplasia) at the tumour edge were associated with unfavourable stage distributions, but each of these features also had an independent effect on prognosis.

Entities:  

Mesh:

Year:  1989        PMID: 2921357      PMCID: PMC1141819          DOI: 10.1136/jcp.42.2.162

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  THE GRADING AND PROGNOSIS OF CARCINOMA OF THE COLON AND RECTUM.

Authors:  R S Grinnell
Journal:  Ann Surg       Date:  1939-04       Impact factor: 12.969

2.  Correlation of histopathologic characteristics of primary tumor and uninvolved regional lymph nodes in Dukes' class C colonic carcinoma with prognosis.

Authors:  G S Thynne; L H Weiland; C G Moertel; A Silvers
Journal:  Mayo Clin Proc       Date:  1980-04       Impact factor: 7.616

3.  Prognosis in colon cancer: a pathologic reassessment.

Authors:  D Murray; A Hreno; J Dutton; L G Hampson
Journal:  Arch Surg       Date:  1975-08

4.  Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology.

Authors:  N Zamcheck; W G Doos; R Prudente; B B Lurie; L S Gottlieb
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

5.  An immunohistological study of cells infiltrating progressive and regressive tumors induced by two variant subpopulations of a rat colon cancer cell line.

Authors:  M S Martin; A Caignard; A Hammann; H Pelletier; F Martin
Journal:  Int J Cancer       Date:  1987-07-15       Impact factor: 7.396

6.  The analysis of mononuclear cell infiltrations in colorectal adenocarcinoma.

Authors:  B Koch; J Giedl; P Hermanek; J R Kalden
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

7.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Authors:  J R Jass; W S Atkin; J Cuzick; H J Bussey; B C Morson; J M Northover; I P Todd
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

8.  Lymphocytic infiltration and survival in rectal cancer.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

9.  Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms.

Authors:  A Csiba; H L Whitwell; M Moore
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

10.  Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.

Authors:  B M Vose; P Gallagher; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

View more
  41 in total

1.  Morphological predictors of survival in early and advanced gastric carcinoma.

Authors:  P Schmitz-Moormann; P Hermanek; G W Himmelmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Prognostic variables in large bowel cancer.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

3.  Lymph node evaluation for colon cancer in routine clinical practice: a population-based study.

Authors:  J C Del Paggio; S Nanji; X Wei; P H MacDonald; C M Booth
Journal:  Curr Oncol       Date:  2017-02-27       Impact factor: 3.677

4.  Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer.

Authors:  Teppei Morikawa; Aya Kuchiba; Zhi Rong Qian; Mari Mino-Kenudson; Jason L Hornick; Mai Yamauchi; Yu Imamura; Xiaoyun Liao; Reiko Nishihara; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  Ann Surg Oncol       Date:  2011-12-22       Impact factor: 5.344

5.  Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors.

Authors:  Toshiyuki Nakayama; Go Hatachi; Chun-Yang Wen; Ayumi Yoshizaki; Kazuyuki Yamazumi; Daisuke Niino; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

6.  Histological factors contributing to a high risk of recurrence of submucosal invasive cancer (pT1) of the colon and rectum after endoscopic therapy.

Authors:  Ichiro Nakada; Takanobu Tabuchi; Takeshi Nakachi; Jiro Shimazaki; Satoru Konishi; Motonobu Katano; Hideyuki Ubukata; Yoshihisa Goto; Yoshinori Watanabe; Takafumi Tabuchi
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

7.  The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients.

Authors:  N P West; M Dattani; P McShane; G Hutchins; J Grabsch; W Mueller; D Treanor; P Quirke; H Grabsch
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

Review 8.  The role of fibroblasts in tumor behavior.

Authors:  M Grégoire; B Lieubeau
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

9.  Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer.

Authors:  V C Petersen; K J Baxter; S B Love; N A Shepherd
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Tumor-Infiltrating Lymphocytes and Colorectal Cancer Survival in African American and Caucasian Patients.

Authors:  Kristin Wallace; David N Lewin; Shaoli Sun; Clayton M Spiceland; Don C Rockey; Alexander V Alekseyenko; Jennifer D Wu; John A Baron; Anthony J Alberg; Elizabeth G Hill
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-05-16       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.